Skip to content

BIOSYNERGY INC: 10-Q/A filed 2022-03-28

What BIOSYNERGY INC reported in its quarterly report amendment filed 2022-03-28 (fiscal Q3 2022): 31 published measures, 82 facts as tagged in accession 0001437749-22-007349.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form
10-Q/A (quarterly report amendment)
Filed
2022-03-28
Fiscal period
fiscal Q3 2022
Accession
0001437749-22-007349 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All BIOSYNERGY INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2022-01-312,989,669USD
At 2021-04-301,891,514USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2022-01-310USD
At 2021-04-301,738,996USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2021-11-01 to 2022-01-31763,132USD92
2021-05-01 to 2022-01-31697,253USD276
2020-11-01 to 2021-01-31-235USD92
2020-05-01 to 2021-01-3114,688USD276

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2021-05-01 to 2022-01-31-120,515USD276
2020-05-01 to 2021-01-3128,572USD276

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2021-05-01 to 2022-01-311,354,496USD276
2020-05-01 to 2021-01-319,500USD276

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2022-01-310USD
At 2021-04-301,102,870USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2021-11-01 to 2022-01-31269,234USD92
2021-05-01 to 2022-01-31242,973USD276
2020-11-01 to 2021-01-31-93USD92
2020-05-01 to 2021-01-315,855USD276

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2022-01-310USD
At 2021-04-303,063USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2021-11-01 to 2022-01-31-206,829USD92
2021-05-01 to 2022-01-31-300,126USD276
2020-11-01 to 2021-01-31-10,425USD92
2020-05-01 to 2021-01-319,229USD276

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2022-01-312,967,647USD
At 2021-04-301,694,529USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2022-01-312,989,669USD
At 2021-04-30127,526USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2022-01-3179,263USD
At 2021-04-303,189USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2022-01-31286,646USD
At 2021-04-30264,509USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2021-11-01 to 2022-01-31404,709USD92
2021-05-01 to 2022-01-31817,845USD276
2020-11-01 to 2021-01-31176,205USD92
2020-05-01 to 2021-01-31539,592USD276

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2022-01-310USD
At 2021-04-30145,178USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2021-11-01 to 2022-01-31197,880USD92
2021-05-01 to 2022-01-31517,719USD276
2020-11-01 to 2021-01-31165,780USD92
2020-05-01 to 2021-01-31548,921USD276

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2021-11-01 to 2022-01-31128,155USD92
2021-05-01 to 2022-01-31505,175USD276
2020-11-01 to 2021-01-3199,318USD92
2020-05-01 to 2021-01-31321,136USD276

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2021-11-01 to 2022-01-3127,253USD92
2021-05-01 to 2022-01-3186,563USD276
2020-11-01 to 2021-01-3143,075USD92
2020-05-01 to 2021-01-31119,915USD276

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2022-01-3116,095USD
At 2021-04-3096,570USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2022-01-310USD
At 2021-04-30202,621USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2022-01-310USD
At 2021-04-30199,558USD

Net deferred tax liabilities

Deferred tax liabilities net of related assets under this concept. The amount reflects timing differences and is not tax currently due.

PeriodValueUnitDays
At 2022-01-310USD
At 2021-04-3024,992USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2021-11-01 to 2022-01-311,032,366USD92
2021-05-01 to 2022-01-31940,226USD276
2020-11-01 to 2021-01-31-328USD92
2020-05-01 to 2021-01-3120,543USD276

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2021-11-01 to 2022-01-31355,396USD92
2021-05-01 to 2022-01-31652,464USD276
2020-11-01 to 2021-01-3191,090USD92
2020-05-01 to 2021-01-31293,582USD276

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2021-05-01 to 2022-01-313,062USD276
2020-05-01 to 2021-01-313,348USD276

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2021-05-01 to 2022-01-319,096USD276
2020-05-01 to 2021-01-3110,233USD276

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2021-11-01 to 2022-01-311,239,195USD92
2021-05-01 to 2022-01-311,240,352USD276
2020-11-01 to 2021-01-3110,097USD92
2020-05-01 to 2021-01-3111,314USD276

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2021-05-01 to 2022-01-31-24,992USD276
2020-05-01 to 2021-01-310USD276

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2021-05-01 to 2022-01-310USD276
2020-05-01 to 2021-01-310USD276

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2021-05-01 to 2022-01-3122,137USD276
2020-05-01 to 2021-01-31-34,163USD276

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2021-05-01 to 2022-01-3138,328USD276
2020-05-01 to 2021-01-3129,193USD276

Inspect the source

Entity
BIOSYNERGY INC / CIK 0000715812
Captured
SEC response SHA-256
eb912604535d1396c8e2ed6025c6adab35af75fdfc7239083d444e5a31df6a03

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000715812.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))